News
Essential Pharma strengthens Board with the appointment of Nicola Heffron as Non-Executive Director Egham, UK – 25 June 2025 – Essential Pharma (“Essential” or “the Company”), a global pharmaceutical ...
Late-stage pipeline products can generate demand in the MG market and with diagnosed prevalent cases, will drive growth in ...
For the second time in nine months, a Delaware judge has sided (PDF) with Syntimmune shareholders over AstraZeneca, granting a $181 million award. The decision comes on top of a $130 million verdict ...
An AstraZeneca Plc affiliate suffered a greater than $180 million court loss Wednesday over its lackluster efforts to ...
15d
Medical Device Network on MSNAstraZeneca and Pangaea partner for AI detection of hypophosphatasiaAstraZeneca’s rare disease business, Alexion, has partnered with British health tech Pangaea Data to fund the startup’s ...
Recursion Pharmaceuticals grew its share prices by 20.13 percent on Friday to close at $5.49 apiece following the unveiling of Boltz-2, touted as the next-generation AI model to predict binding ...
20d
MedPage Today on MSNTwo Drugs Better Than One for Easing Albuminuria in CKD Patients With DiabetesAn SGLT2 inhibitor combined with a nonsteroidal mineralocorticoid receptor antagonist quickly cut urinary albumin-to-creatinine ratio (UACR) in patients with albuminuria and both chronic kidney ...
Trump’s tariff threat exposes China’s tight grip on the global pharmaceuticals industry ...
The Regeneron Pharmaceuticals company logo is seen on a building at the company's Westchester campus in Tarrytown, New York, U.S. September 17, 2020. Picture taken September 17, 2020.
Sun Pharma has acquired all outstanding shares of Checkpoint at a price of $4.10 per share in cash, without interest, plus one non-tradable contingent value right (CVR) per share representing the ...
AACE pharmaceuticals was slammed in a warning letter by the FDA that cited significant violations by its contract manufacturer Brassica Pharma, including sanitary conditions and made up lab records.
Tonix Pharmaceuticals Corp. (NASDAQ:TNXP) shares have nearly doubled over the past month. Here's what you need to know.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results